2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   6

Issue No. :  4

Year :  2013

Pages :   388-391

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Development and Validation of Spectrophotometric Method for the Determination of Risperidone in pure and Pharmaceutical Formulation using MBTH reagent



Address:   Mrs. Sheeja Velayudhan Kutty, Greeshma S.*, Vidhya P.M., Mr. D. K. Sunith
Department of Pharmaceutical Analysis, Grace College of Pharmacy, Kodunthirapully Post, Palakkad, Kerala, India, Pin 678004
Grace College of Pharmacy, Palakkad, Kerala
Cresent College of Pharmaceutical Sciences, Kannur, Kerala
*Corresponding Author
DOI No: Not Available

ABSTRACT:
A simple, sensitive, precise and accurate UV-Visible spectrophotometric method has been developed for the determination of Risperidone in bulk drug and pharmaceutical formulation (tablet). The method is based on the oxidative coupling reaction of the drug with 3-Methyl-2-Benzthiazolinone hydrochloride (MBTH) in the presence of Ferric chloride Fe (III) to form green coloured chromogen exhibiting Lambda max at 666nm. Beer’s law was obeyed over the concentration range of 4-14µg/ml with a linear regression value 0.993.The method was validated in accordance with the current ICH guidelines. Interday and Intraday studies showed high degree of repeatability, recoveries obtained do not differ significantly from 100% showed accuracy and reliability of the method. The proposed method was applied successfully for the determination of Risperidone in pure bulk form and in tablets without interference from commonly encountered additives.
KEYWORDS:
Risperidone, UV Visible spectrophotometry, MBTH, Validation
Cite:
Sheeja Velayudhan Kutty, Greeshma S., Vidhya P.M., D. K. Sunith. Development and Validation of Spectrophotometric Method for the Determination of Risperidone in pure and Pharmaceutical Formulation using MBTH reagent. Research J. Pharm. and Tech. 6(4): April 2013; Page 388-391.
[View HTML]      [View PDF]



Visitor's No. :   655807